BPTH Bio Path Holdings Inc

USD 1.96 0.00 0
Icon

Bio Path Holdings Inc (BPTH) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.96

0.00 (0.00)%

USD 3.89M

0.14M

N/A

N/A

Icon

BPTH

Bio Path Holdings Inc (USD)
COMMON STOCK | NSD
USD 1.96
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.89M

N/A

USD 1.96

Bio Path Holdings Inc (BPTH) Stock Forecast

N/A

Based on the Bio Path Holdings Inc stock forecast from 0 analysts, the average analyst target price for Bio Path Holdings Inc is not available over the next 12 months. Bio Path Holdings Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bio Path Holdings Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Bio Path Holdings Inc’s stock price was USD 1.96. Bio Path Holdings Inc’s stock price has changed by +14.62% over the past week, -9.26% over the past month and -92.46% over the last year.

No recent analyst target price found for Bio Path Holdings Inc
No recent average analyst rating found for Bio Path Holdings Inc

Company Overview Bio Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is ...Read More

4710 Bellaire Boulevard, Bellaire, TX, United States, 77401

10

December

USD

USA

Adjusted Closing Price for Bio Path Holdings Inc (BPTH)

Loading...

Unadjusted Closing Price for Bio Path Holdings Inc (BPTH)

Loading...

Share Trading Volume for Bio Path Holdings Inc Shares

Loading...

Compare Performance of Bio Path Holdings Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BPTH

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bio Path Holdings Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing BPTH

Symbol Name BPTH's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bio Path Holdings Inc (BPTH) Stock

Stock Target Advisor's fundamental analysis for Bio Path Holdings Inc's stock is Very Bearish.

Unfortunately we do not have enough data on BPTH's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BPTH's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BPTH's stock to indicate if its overvalued.

The last closing price of BPTH's stock was USD 1.96.

The most recent market capitalization for BPTH is USD 3.89M.

Unfortunately we do not have enough analyst data on BPTH's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bio Path Holdings Inc's stock.

As per our most recent records Bio Path Holdings Inc has 10 Employees.

Bio Path Holdings Inc's registered address is 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401. You can get more information about it from Bio Path Holdings Inc's website at https://www.biopathholdings.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...